Found 14 articles for: "cost"
Central Centrifugal Cicatricial Alopecia and the Use of Xtressé Nutrient Supplement: A Case Series
November 2026 | Volume 25 | Issue 11 | Case Reports | 1072 | Copyright © November 2026
Central Centrifugal Cicatricial Alopecia (CCCA) is a form of scarring alopecia characterized by patches of permanent hair loss that manifests on the crown of the scalp, progressively spreading ou...
Read MoreDecoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America
July 2026 | Volume 25 | Issue 7 | Original Article | 632 | Copyright © July 2026
Background: Sensitive skin syndrome (SSS) is a common self-reported condition, more prevalent in women, characterized by redness, irritation, and discomfort in response to variou...
Read MorePerspectives and Practice Patterns of Dermatologists Using Laser Hair Removal for Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Editorials | e71 | Copyright © December 2025
Understanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1057 | Copyright © October 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
Increasing Concern Over the Cost of Facial Cosmetic Dermatological Procedures Since the Onset of COVID-19
September 2025 | Volume 24 | Issue 9 | Features | 940 | Copyright © September 2025
Precision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
Socioeconomic Disparities in Gentle Skin Care Access for Atopic Dermatitis: Affordability and Pharmacy Deserts
July 2025 | Volume 24 | Issue 7 | Original Article | 683 | Copyright © July 2025
Background: Gentle skin care is key to atopic dermatitis (AD) treatment, yet products are often expensive. Pharmacy deserts may exacerbate socioeconomic disparities in AD....
Read MoreNeed for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
June 2025 | Volume 24 | Issue 6 | Case Reports | 634 | Copyright © June 2025
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used...
Read MorePlacental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis
May 2025 | Volume 24 | Issue 5 | Original Article | 450 | Copyright © May 2025
Read MoreTopical Corticosteroid Potencies: Reimagining A New Universal Classification System
May 2025 | Volume 24 | Issue 5 | Original Article | 458 | Copyright © May 2025
Topical corticosteroids (TCS) are an effective and generally tolerable class of medications frequently used for a wide variety of dermatologic conditions. There are many currently available TCS, ...
Read MoreOff-Label Management Strategies for Generalized Granuloma Annulare: What's New?
April 2025 | Volume 24 | Issue 4 | Features | 425 | Copyright © April 2025
Comparative Efficacy of Intralesional Steroid Injections vs Cryotherapy for the Treatment of Alopecia Areata
March 2025 | Volume 24 | Issue 3 | Original Article | 294 | Copyright © March 2025
Introduction: The precise etiology of alopecia areata (AA) remains unclear. Various treatments, including corticosteroids, minoxidil, immunotherapy, and phototherapy, have shown ...
Read MoreConsensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 736 | Copyright © August 2023
This article aims to provide consensus statements on the use of corticosteroid-containing topical medications for the management of psoriasis. This Psoriasis Expert Group (PEG) includes dermatolo...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
